Live from the NIH registry
Studies recruiting near Flint right now
Top 25 of 167 recruiting studies, sorted by proximity — each links to its official registry page
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
GenesisCare USA - Clarkston — Clarkston, Michigan (24.2 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
McLaren Cancer Institute-Flint — Flint, Michigan (0.8 mi)
· Sponsor: NRG Oncology
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Wright & Filippis x Ottobock.care — Flint, Michigan (0.8 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
Intracranial Aneurysm
N/A
Observational 118 participants sought
McLaren Healthcare — Flint, Michigan (0.8 mi)
· Sponsor: Medtronic Neurovascular Clinical Affairs
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 2
Interventional 180 participants sought
AA Medical Research Center - Grand Blanc /ID# 272496 — Grand Blanc, Michigan (7.3 mi)
· Sponsor: AbbVie
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
Breast Cancer, Breast Neoplasm
Phase 2
Interventional 132 participants sought
McLaren Proton Therapy Center — Flint, Michigan (0.8 mi)
· Sponsor: Proton Collaborative Group
Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas
Pancreatic Cancer
Phase 2
Interventional 60 participants sought
McLaren Proton Therapy Center — Flint, Michigan (0.8 mi)
· Sponsor: Proton Collaborative Group
Scaling up Maternal Health Equity Best Practices
Maternal Mortality Disparities, Maternal Morbidity Disparities
N/A
Interventional 600 participants sought
Michigan State University on behalf on 12 Michigan counties — Flint, Michigan (0.8 mi)
· Sponsor: Michigan State University
A Study to Evaluate Efficacy, Safety, and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)
Chronic Pruritus of Unknown Origin
Phase 3
Interventional 180 participants sought
Michigan Center for Rsrch Company — Clarkston, Michigan (24.2 mi)
· Sponsor: Novartis Pharmaceuticals
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
McLaren Cancer Institute-Flint — Flint, Michigan (0.8 mi)
· Sponsor: NRG Oncology
The Cancer Stage Shifting Initiative: Registry and Biorepository to Research and Address Health Disparities in Cancer Care
Cancer, Cancer Comorbidities
N/A
Observational 100,000 participants sought
Life in 3D Health Services — Flint, Michigan (0.8 mi)
· Sponsor: National Minority Quality Forum
Study of Aritinercept in Patients With Generalized Myasthenia Gravis
Myasthenia Gravis, Generalized
Phase 1, Phase 2
Interventional 81 participants sought
Aurinia Investigational Site — Flint, Michigan (0.8 mi)
· Sponsor: Aurinia Pharmaceuticals Inc.
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Graves' Disease
Phase 2
Interventional 240 participants sought
Site Number - 1069 — Flint, Michigan (0.8 mi)
· Sponsor: Immunovant Sciences GmbH
Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies
Advanced Solid Tumor
Phase 1
Interventional 60 participants sought
Karmanos Cancer Institute at McLaren Flint — Flint, Michigan (0.8 mi)
· Sponsor: Barbara Ann Karmanos Cancer Institute
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Michigan Dermatology Institute - Waterford- Site Number : 8400013 — Waterford, Michigan (26.9 mi)
· Sponsor: Sanofi
Train Your Brain 2.0 - Improving Memory and Decision Making Among Youth
Behavior, Health
N/A
Interventional 72 participants sought
Freedom Schools Collaborative — Flint, Michigan (0.8 mi)
· Sponsor: Wayne State University
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Myelodysplastic Syndrome
Phase 2
Interventional 54 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
Pyoderma Gangrenosum
Phase 3
Interventional 90 participants sought
Dermatology & Cosmetic Center PLLC - Flint — Flint, Michigan (0.8 mi)
· Sponsor: LEO Pharma
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: SWOG Cancer Research Network
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Atrial Fibrillation (AF)
Phase 2
Interventional 1,200 participants sought
AA Medical Research Center (MRC) — Flint, Michigan (0.8 mi)
· Sponsor: Regeneron Pharmaceuticals
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Colorectal Cancer, Sarcopenia
N/A
Observational 300 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: Wake Forest University Health Sciences
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: SWOG Cancer Research Network
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Hidradenitis Suppurativa (HS)
Phase 3
Interventional 600 participants sought
Investigative Site US042 — Waterford, Michigan (26.9 mi)
· Sponsor: Incyte Corporation
ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer
Malignant Ovarian Epithelial Tumor, Platinum-Resistant Fallopian Tube Carcinoma
Phase 2
Interventional 62 participants sought
Karmanos Cancer Institute at McLaren Flint — Flint, Michigan (0.8 mi)
· Sponsor: Ira Winer
Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer
Metastatic Colorectal Adenocarcinoma
Phase 2
Interventional 102 participants sought
Karmanos Cancer Institute at McLaren Flint — Flint, Michigan (0.8 mi)
· Sponsor: Barbara Ann Karmanos Cancer Institute